Luoxis To Present Findings From Clinical Study Of Traumatic Brain Injury

(RTTNews) - Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc. (AMPE), Tuesday announced an upcoming presentation at the 73rd Annual Meeting of the American Academy of Surgical Trauma or AAST and Clinical Congress of Acute Care Surgery in Philadelphia, Pennsylvania that will be held from September 10 to 13.

The presentation will report results from a recently completed five-year prospective clinical trial conducted using Luoxis' proprietary RedoxSYS oxidation-reduction potential or ORP diagnostic platform to assess prognosis and outcomes in patients with traumatic brain injury.

This multi-center study on traumatic brain injury was conducted by Luoxis' research partner Trauma Research, LLC in collaboration with Swedish Medical Center in Englewood, Colorado, Saint Anthony Hospital in Lakewood, Colorado, Centura Health System in Denver, Colorado, and the Medical Center of Plano in Plano, Texas.